Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity
Open Access
- 11 September 2024
- journal article
- research article
- Published by Brieflands in Iranian Journal of Pharmaceutical Research
- Vol. 23 (1) , e147246
Abstract
Background: High mobility group box 1 (HMGB1) plays an essential role in various pathological conditions, including inflammation, fibrosis, autoimmune diseases, and carcinogenesis. The quantification of HMGB1 in body fluids holds promise for clinical applications. Objectives: This study aimed to isolate high-affinity single-stranded DNA (ssDNA) aptamers that target HMGB1. Methods: In this study, ssDNA aptamers were selected using Systematic Evolution of Ligands by Exponential Enrichment (SELEX). The affinity and specificity of the aptamers were evaluated through South-Western blot analysis, enzyme-linked aptamer sorbent assay (ELASA), and aptamer-based histochemistry staining. The impact of the aptamers on the biological activity of HMGB1 was tested in the human acute monocytic leukemia cell line, THP-1. Results: An aptamer (H-ap25, dissociation constant = 8.20 ± 0.53 nmol/L) with high affinity for the HMGB1 B box was generated. Further experiments verified that H-ap25 can be used to detect HMGB1 in South-Western blot analysis, ELASA, and aptamer-based histochemistry staining. Moreover, H-ap25 significantly augmented HMGB1-induced expression of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, Toll-like receptor 9 (TLR9), and activation of NF-κB in THP-1 cells. Conclusions: Our results demonstrated that H-ap25 can be used both as an enhancer of HMGB1 and as a probe in research.Keywords
This publication has 35 references indexed in Scilit:
- HMGB1 as biomarker and drug targetPharmacological Research, 2016
- Near-infrared light-activated cancer cell targeting and drug delivery with aptamer-modified nanostructuresNano Research, 2015
- Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO2 Nanosheet–Aptamer NanoprobeJournal of the American Chemical Society, 2014
- Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis opticaNeuroscience, 2012
- Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and TherapyChemMedChem, 2008
- The HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanismBiochemical and Biophysical Research Communications, 2007
- Recombinant HMGB1 with cytokine-stimulating activityJournal of Immunological Methods, 2004
- Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1Molecular Medicine, 2003
- Removal of Endotoxin from Recombinant Protein PreparationsClinical Biochemistry, 1997
- The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins.The EMBO Journal, 1992